Beijing Continent Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
479
- Latest Deal Type
-
M&A
- Investors
-
2
Beijing Continent General Information
Description
Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
Contact Information
Website
www.bjcontinent.comCorporate Office
- 6th floor, Fuze Life Insurance Building
- Number 1 Building, Wangjing Dongyuan 4 District, Chaoyang District
- Beijing
- China
Corporate Office
- 6th floor, Fuze Life Insurance Building
- Number 1 Building, Wangjing Dongyuan 4 District, Chaoyang District
- Beijing
- China
Beijing Continent Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 30-Oct-2023 | Completed | Profitable | |||
| 8. IPO | 28-Feb-2022 | Cancelled | Profitable | |||
| 7. Secondary Transaction - Private | 17-Nov-2020 | Completed | Profitable | |||
| 6. IPO | Cancelled | Profitable | ||||
| 5. Secondary Transaction - Private | 23-Dec-2015 | Completed | Profitable | |||
| 4. Secondary Transaction - Private | 24-Feb-2014 | Completed | Profitable | |||
| 3. Later Stage VC | 23-Oct-2013 | Completed | Profitable | |||
| 2. Merger/Acquisition | 14-Oct-2011 | $2.11M | Completed | Profitable | ||
| 1. Secondary Transaction - Private | 11-Apr-2006 | $1.04M | Completed | Generating Revenue |
Beijing Continent Patents
Beijing Continent Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026158571-A1 | Use of hydronidone in treating metabolic dysfunction-associated steatotic liver disease | Pending | 25-Jan-2025 | ||
| WO-2026077441-A1 | Compositions and methods for preventing and treating chronic kidney disease | Pending | 12-Oct-2024 | ||
| WO-2026077440-A1 | Compositions and methods for preventing and treating chronic renal failure | Pending | 12-Oct-2024 | ||
| WO-2026026911-A1 | Use of dipeptide derivative | Pending | 02-Aug-2024 | ||
| EP-4520344-A1 | Dipeptide derivative composition, preparation method therefor, and use thereof | Pending | 06-May-2022 | C07K5/06026 |
Beijing Continent Signals
Beijing Continent Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Continent Factory | Corporation | Minority | ||
| Gyre Therapeutics | Corporation | Majority | ||
| Lapam Capital | Venture Capital | Minority |
Beijing Continent FAQs
-
When was Beijing Continent founded?
Beijing Continent was founded in 2002.
-
Where is Beijing Continent headquartered?
Beijing Continent is headquartered in Beijing, China.
-
What is the size of Beijing Continent?
Beijing Continent has 479 total employees.
-
What industry is Beijing Continent in?
Beijing Continent’s primary industry is Drug Discovery.
-
Is Beijing Continent a private or public company?
Beijing Continent is a Private company.
-
What is Beijing Continent’s current revenue?
The current revenue for Beijing Continent is .
-
How much funding has Beijing Continent raised over time?
Beijing Continent has raised $1.64M.
-
Who are Beijing Continent’s investors?
Beijing Continent Factory, Gyre Therapeutics, and Lapam Capital have invested in Beijing Continent.
-
When was Beijing Continent acquired?
Beijing Continent was acquired on 30-Oct-2023.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process